SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-23-040981
Filing Date
2023-12-07
Accepted
2023-12-07 07:02:48
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A avtx-additionalmaterialsde.htm DEFA14A 37939
2 GRAPHIC avalologoa.jpg GRAPHIC 8535
3 GRAPHIC morrowsodalilogo.jpg GRAPHIC 4500
  Complete submission text file 0001628280-23-040981.txt   57252
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37590 | Film No.: 231471056
SIC: 2834 Pharmaceutical Preparations